SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-069812
Filing Date
2008-11-10
Accepted
2008-11-10 17:11:16
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-25757_110q.htm 10-Q 1091213
2 EX-3.7 a08-25757_1ex3d7.htm EX-3.7 12553
3 EX-31.1 a08-25757_1ex31d1.htm EX-31.1 19177
4 EX-31.2 a08-25757_1ex31d2.htm EX-31.2 19626
5 EX-32.1 a08-25757_1ex32d1.htm EX-32.1 10228
  Complete submission text file 0001104659-08-069812.txt   1154390
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 081176729
SIC: 2835 In Vitro & In Vivo Diagnostic Substances